0001209191-21-015098.txt : 20210301
0001209191-21-015098.hdr.sgml : 20210301
20210301103441
ACCESSION NUMBER: 0001209191-21-015098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210301
DATE AS OF CHANGE: 20210301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bisker-Leib Vered
CENTRAL INDEX KEY: 0001814093
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39696
FILM NUMBER: 21695329
MAIL ADDRESS:
STREET 1: C/O COMPASS
STREET 2: 245 FIRST STREET, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Compass Therapeutics, Inc.
CENTRAL INDEX KEY: 0001738021
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-500-8099
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Olivia Ventures, Inc.
DATE OF NAME CHANGE: 20180419
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-09
0
0001738021
Compass Therapeutics, Inc.
CMPX
0001814093
Bisker-Leib Vered
C/O COMPASS THERAPEUTICS
80 GUEST STREET, SUITE 601
BOSTON
MA
02135
0
1
0
0
President & COO
Stock Option (Right to Buy)
5.00
2021-02-09
4
A
0
400000
0.00
A
2031-02-09
Common Stock
400000
400000
D
25% of this option vests on February 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
/s/ Vered Bisker-Leib
2021-03-01